Structure and transcription regulation of the human Insulin-like Growth Factor Binding Protein 4 Gene (IGFBP4)

Genomics

Volumn 49, Issue 3, 1998, Pages 401-410

  Zazzi, Henric ^a   Nikoshkov, Andrej ^a   Hall, Kerstin ^a   Luthman, Holger ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP;

AMINO ACID ANALYSIS; ARTICLE; DNA FLANKING REGION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE STRUCTURE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INTRON; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RNA TRANSLATION; TATA BOX;

EID: 0031837003     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5283     Document Type: Article

References (66)

1. Allander V., Larsson C., Ehrenborg E., Suwanichkul A., Weber G., Morris S. L., Bajalica S., Kiefer M. C., Luthman H., Powell D. R. Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5. J. Biol. Chem. 269:1994;10891-10898.
2. Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herrlich P., Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting enhancer. Cell. 49:1987;729-739.
3. Bajalica S., Vilhemsdotter S., Ehrenborg E., Brøndum-Nielsen K., Luthman H., Larsson C. Localization of the human insulin-like growth factor-binding protein 4 gene to chromosomal region 17q12-21.2. Hum. Genet. 89:1992;234-236.
4. Baum C., Forster P., Hegewisch-Becker S., Harbers K. An optimized electroporation protocol applicable to a wide range of cell lines. Biotechniques. 17:1994;1058-1062.
5. Baxter R. C., Martin J. L. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: Determination by reconstitution and affinity-labeling. Proc. Natl. Acad. Sci. USA. 86:1989;6898-6902.
6. Berger S. L., Kimmel A. R. Guide to Molecular Cloning Techniques. 1987;Academic Press, San Diego.
7. Blum W. F., Jenne E. W., Reppin F., Kietzmann K., Ranke M. B., Bierich J. R. Insulin-like growth factor I (IGF-I) binding protein complex is a better mitogen than free IGF-I. Endocrinology. 125:1989;766-772.
8. Breatnach R., Chambon P. Organization and expression of eukaryotic split genes coding for proteins. Annu. Rev. Biochem. 50:1981;349-383.
9. Calabretta B., Robberson D. L., Barrera-Saldãna H. A., Lambrou T. P., Saunders G. F. Genome instability in a region of human DNA enriched in Alu repeat sequences. Nature. 296:1982;219-225.
10. Cohick W. S., Gockerman A., Clemmons D. R. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors. J. Cell. Physiol. 157:1993;52-60.
11. Conover C. A., Clarkson J. T., Bale L. K. Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts. Endocrinology. 136:1995;1403-1410.
12. Conover C. A., Kiefer M. C., Zapf J. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. J. Clin. Invest. 91:1993;1129-1137.
13. Courtois S. J., Lafointaine D. A., Lemaigre F. P., Durviaux S. M., Rousseau G. G. Nuclear factor-I and activator protein-2 bind in a mutually exclusive way to overlapping promoter sequences and trans-activate the human growth hormone gene. Nucleic Acids Res. 18:1990;57-64.
14. Cubbage M. L., Suwanichkul A., Powell D. R. Insulin-like growth factor binding protein 3 (IGFBP-3) organization of the human chromosomal gene and demonstration of the promoter activity. J. Biol. Chem. 265:1990;12642-12649.
15. Culouscou J. M., Shoyab M. Purification of a colon cancer cell growth inhibitor and its identification as insulin-like growth factor binding protein-4. Cancer Res. 51:1991;2813-2819.
16. Dai B., Widen S. G., Mifflin R., Singh P. Cloning of the functional promoter for human insulin-like growth factor binding protein-4 gene: Endogenous regulation. Endocrinology. 138:1997;332-343.
17. Dear S., Staden R. A sequence assembly and editing for efficient management of large projects. Nucleic Acids Res. 19:1991;3907-3911.
18. DeChiara T. M., Efstratiadis A., Robertson E. J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 345:1990;78-80.
19. DeChiara T. M., Robertson E. J., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 64:1991;849-859.
20. Ehrenborg E., Larsson C., Stern I., Janson M., Powell D. R., Luthman H. Contiguous localization of the genes encoding human insulin-like growth factor binding protein 1 (IGFBP1) and 3 (IGFBP3) on chromosome 7. Genomics. 12:1992;497-502.
21. Ehrenborg E., Vilhemsdotter S., Bajalica S., Larsson C., Stern I., Koch J., Brøndum-Nielsen K., Luthman H. Structure and localization of the human insulin-like growth factor binding protein 2 gene. Biochem. Biophys. Res. Commun. 176:1991;1250-1255.
22. Ehrenborg, E. Zazzi, H. Bajalica, S. Granqvist, M. Hillerbrand, U. Allander, S. V. Larsson, C. Luthman, H. 1997, Structural characterization and chromosomal localization of the human insulin-like growth factor-binding protein 6 gene.
23. Elgin R. G., Busby W. H., Clemmons D. R. An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc. Natl. Acad. Sci. USA. 84:1987;3254-3258.
24. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction fragments to high specific activity: Addendum. Anal. Biochem. 137:1984;266-267.
25. Forman B. M., Samuels H. H. Mol. Endocrinol. 4:1990;1293-1301.
26. Gil A., Proudfoot N. J. A sequence downstream of AAUAAA is required for rabbit ß-globin 3′ end formation. Nature. 312:1984;473-474.
27. Glisin V., Crkvenjakov R., Byus C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry. 13:1974;2633-2637.
28. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
29. Guler H.-P., Zapf J., Scheiwiller E., Froesch E. R. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc. Natl. Acad. Sci. USA. 85:1988;4889-4893.
30. Guo Z., Sherman F. 3′-end-forming signals of yeast mRNA. Mol. Cell. Biol. 15:1995;5983-5990.
31. Gutierrez G. E., Mundy G. R., Derynck R., Hewlett E. L., Katz M. S. Inhibition of parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by transforming growth factor alpha and epidermal growth factor. J. Biol. Chem. 262:1987;15845-15850.
32. Houck C. M., Rinehart F. P., Schmid C. W. A ubiquitous family of repeated DNA sequences in the human genome. J. Mol. Biol. 132:1979;289-306.
33. Hultman T., Ståhl S., Hornes E., Uhlén M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res. 17:1989;4937-4945.
34. Jones J. I., Clemmons D. R. Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev. 16:1995;3-34.
35. La Tour D., Mohan S., Linkhart T. A., Baylink D., Strong D. Inhibitory insulin-like growth factor binding protein: Cloning, complete sequence, and physiological regulation. Mol. Endocrinol. 4:1990;1806-1814.
36. Lehrman M. A., Goldstein J. L., Russell D. W., Brown M. S. Duplication of seven exons in LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemia. Cell. 48:1987;827-835.
37. Liu J. P., Baker J., Perkins A. S., Robertson E. J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (igf1r). Cell. 75:1993;59-72.
38. Majello B., Arcone R., Toniatti C., Ciliberto G. Constitutive and IL-6-induced nuclear factors that interact with the human C-reactive protein promoter. EMBO J. 9:1990;457-465.
39. Markert M. L., Hutton J. J., Wiginton D. A., States J. C., Kaufman R. E. Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements. J. Clin. Invest. 81:1988;1323-1327.
40. Meijer D., Hermans A., von Lindern M., van Agthoven T., de Klein A. Molecular characterization of the testis specific c-abl mRNA in mouse. EMBO J. 6:1987;4041-4048.
41. Miller S., Dykes D., Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
42. Mitchell G. A. Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: A role for Alu elements in human mutation. Proc. Natl. Acad. Sci. USA. 88:1991;815-819.
43. Mohan S., Bautista C. M., Wergedal J., Baylink D. J. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action. Proc. Natl. Acad. Sci. USA. 86:1989;8338-8342.
44. Mohan S., Farley J. R., Baylink D. J. Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: Implications for bone loss with aging. Prog. Growth Factor Res. 6:1995;465-473.
45. Murphy L. J., Molnar P., Lu X., Huang H. Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. J. Mol. Endocrinol. 15:1995;293-303.
46. Oh Y., Nagalla S. R., Yamanaka Y., Kim H.-S., Wilson E., Rosenfeld R. G. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. J. Biol. Chem. 271:1996;30322-30325.
47. Powell-Braxton L., Hollinghead P., Warburton C., Dowd M., Pitts-Meek S., Dalton D., Gillett N., Stewart T. A. IGF-I is required for normal embryonic growth in mice. Genes Dev. 7:1993;2609-2617.
48. Proudfoot N. J., Brownlee G. G. Non-coding region sequences in eukaryotic messenger RNA. Nature. 263:1976;211-214.
49. Qin X., Morales S., Lee K.-W., Boonyaratanakornkit V., Baylink D., Mohan S., Strong D. Structural and functional analysis of the 5′-flanking region of the human insulin-like growth factor binding protein (IGFBP)-4 gene. Biochim. Biophys. Acta. 1350:1997;136-140.
50. Rajkumar K., Barron D., Lewitt M. S., Murphy L. J. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology. 136:1995;4029-4034.
51. Roesler W. J., Vanderbark G. R., Hanson R. W. Cyclic AMP and the induction of eukaryotic gene transcription. J. Biol. Chem. 263:1988;9063-9066.
52. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
53. Schmid C. W., Shen C. K. J. The Evolution of Interspersed Repetitive DNA Sequences in Mammals and Other Vertebrates. 1986;Plenum, New York.
54. Schmidt M. C., Zhou Q., Berk A. J. Sp1 activates transcription without enhancing DNA-binding activity of the TATA box factor. Mol. Cell. Biol. 9:1989;3299-3307.
55. Setzer D. R., McGrogan M., Nunberg J. H., Schimke R. T. Size heterogeneity in the 3′ end of dihydrofolate reductase messenger RNAs in mouse cells. Cell. 22:1980;361-370.
56. Sheets M. D., Ogg S. C., Wickens M. P. Point mutations in AAUAAA and the poly(A) addition site: Effects on the accuracy and efficiency of cleavage and polyadenylation in vitro. Nucleic Acids Res. 18:1990;5799-5805.
57. Shimasaki S., Tanahashi H., Onoda N., Sumitomo S., Mickey G. Transcriptional and posttranscriptional regulation of IGFBP-4 and -5 in cultured rat granulosa cells. The Insulin-like Growth Factors and Their Regulatory Proteins. 1994;Elsevier, Amsterdam. p. 193-204.
58. Shimasaki S., Uchiyama F., Shimonaka M., Ling N. Molecular cloning of the cDNA encoding a novel insulin-like growth factor binding-protein from rat and human. Mol. Endocrinol. 4:1990;1451-1458.
59. Skottner A., Clark R. G., Fryklund L., Robinson I. C. A. F. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Endocrinology. 124:1989;2519-2526.
60. Stewart C. E. H., Rotwein P. Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors. Physiol. Rev. 76:1996;1005-1026.
61. Tonin P., Ehrenborg E., Lenoir G., Feunteun J., Lynch H., Morgan K., Zazzi H., Vivier A., Pollak M., Huynh H., Luthman H., Larsson C., Narod S. The human insulin-like growth factor binding protein 4 gene maps to the chromosome region 17q12-q21.1 and is close to the gene for hereditary breast-ovarian cancer. Genomics. 18:1993;414-417.
62. Ullrich A., Shine J., Chirgwin J., Pictet R., Tischer E., Rutter W. J., Goodman H. M. Rat insulin genes: Construction of plasmids containing the coding sequences. Science. 196:1977;1313-1319.
63. Wallace M. R., Andersen L. B., Saulino A. M., Gregory P. E., Glover T. W., Collins F. S. Ade novo. Nature. 353:1991;864-866.
64. Wasyslyk C., Flores P., Gutman A., Wasylyk B. PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes. EMBO J. 8:1989;3371-3378.
65. Xiong Y., Connoly T., Futcher B., Beach D. Human D-type cyclin. Cell. 65:1991;691-699.
66. Zapf J., Waldvogel M., Froesch E. R. Binding of nonsuppressible insulin-like activity to human serum: Evidence for a carrier protein. Arch. Biochem. Biophys. 168:1975;638-645.